Vernal Keratoconjunctivitis: When Allergic Conjunctivitis Threatens the Cornea

Vernal keratoconjunctivitis (VKC) is a chronic, bilateral, allergic inflammation of the conjunctiva that predominantly affects boys in the first two decades of life, with a seasonal pattern that gives the disease its name.

Unlike simple allergic conjunctivitis, VKC is capable of causing genuine corneal damage and permanent visual loss if not managed properly, which is what separates it clinically from the much more common and generally benign seasonal allergic conjunctivitis most clinicians see routinely.

Epidemiology

VKC is more common in warm, dry climates and shows a clear male predominance in childhood, though this sex difference tends to narrow or disappear by adulthood.

Onset is typically before the age of ten, and while the disease often follows a seasonal, spring-predominant pattern in temperate climates, giving rise to the name, presentation can be perennial in warmer regions with less seasonal variation.

A personal or family history of atopy, asthma, eczema, or allergic rhinitis is common, though a meaningful proportion of patients have no other identifiable atopic disease.

Pathophysiology

VKC involves both IgE-mediated type I hypersensitivity and a chronic, cell-mediated inflammatory component, which is why it behaves differently from a simple type I allergic reaction and does not respond as reliably to antihistamines alone.

Eosinophils, mast cells, and activated T-helper-2 lymphocytes infiltrate the conjunctiva, and eosinophil-derived proteins, including major basic protein, are directly toxic to the corneal epithelium.

This is thought to be the principal mechanism behind the epithelial defects and shield ulcers seen in more severe disease, rather than mechanical trauma from the papillae alone, though giant papillae rubbing against the cornea can certainly contribute mechanically as well.

Clinical Presentation

Intense itching is the dominant and most characteristic symptom, typically out of proportion to what is seen with ordinary allergic conjunctivitis, and is often accompanied by photophobia, foreign body sensation, and a thick, ropy, mucoid discharge that patients or parents frequently describe specifically as stringy.

Symptoms are often worse after sun exposure, wind, or physical exertion.

VKC is classified by which conjunctival surface is predominantly involved, and the distinction matters because the complication risk differs between the two forms.

The palpebral form shows giant papillae, classically described as cobblestone in appearance, on the superior tarsal conjunctiva, and this is the form most associated with mechanical corneal complications from papillae rubbing against the ocular surface with every blink.

The limbal form instead shows gelatinous limbal thickening, often with small white points called Horner-Trantas dots, which represent aggregates of degenerated eosinophils and epithelial cells at the limbus.

Corneal involvement is what turns this from an uncomfortable disease into a sight-threatening one. Superficial punctate keratopathy is common in active disease.

In more severe or poorly controlled cases, a shield ulcer, a sterile, oval epithelial defect typically in the superior cornea, can develop from mechanical trauma by overlying giant papillae combined with eosinophil-mediated epithelial toxicity, and this can scar and threaten vision if it is not recognised and treated promptly.

Pseudogerontoxon, a grey, arc-shaped limbal scar resembling arcus senilis but in a young patient, is a residual marker of previous limbal inflammation and, once present, does not itself require treatment.

Differential Diagnosis

Seasonal or perennial allergic conjunctivitis, generally milder, without giant papillae or corneal involvement, and responsive to standard antihistamine and mast cell stabiliser therapy
Giant papillary conjunctivitis, typically related to contact lens wear or an exposed suture, with a relevant history that VKC lacks
Atopic keratoconjunctivitis, which tends to present in an older age group, often with associated eyelid skin changes and a more chronic course extending well beyond childhood
Superior limbic keratoconjunctivitis, which involves the superior bulbar conjunctiva rather than the tarsal conjunctiva and lacks the giant papillae characteristic of VKC

Diagnostic Evaluation

Diagnosis is primarily clinical, based on the characteristic history and slit-lamp findings described above. Conjunctival scraping showing eosinophils can support the diagnosis when the picture is not entirely clear, though it is not required in a typical presentation.

Corneal examination with fluorescein staining is important in every case to look specifically for punctate keratopathy or shield ulceration, since the degree of corneal involvement, not the severity of itching, is what should drive treatment intensity.

Management

Cold compresses and preservative-free artificial tears provide symptomatic relief and are reasonable first steps in mild disease. Topical antihistamines and mast cell stabilisers, or combination agents, form the mainstay of treatment for mild to moderate disease and are generally well tolerated for long-term use, including outside the active season in perennial or high-risk patients.

Topical corticosteroids are necessary for moderate to severe exacerbations and are the most effective agents for controlling acute inflammation, but they carry real risks with prolonged use, including cataract and steroid-induced glaucoma, particularly relevant given how young these patients typically are and how many years of potential exposure lie ahead of them.

The general approach is to use the lowest effective dose for the shortest necessary course, with a clear plan to step down once the acute episode is controlled, rather than maintaining a child on long-term steroid drops by default.

Topical calcineurin inhibitors, particularly ciclosporin, have become an important steroid-sparing option for chronic or recurrent disease, allowing many patients to reduce their reliance on corticosteroids substantially. Tacrolimus ointment is used similarly in some centres.

A shield ulcer needs prompt, aggressive treatment, including topical steroids and sometimes a bandage contact lens or, in severe cases, surgical debridement, since delayed treatment risks permanent corneal scarring at the visual axis.

Prognosis

VKC tends to improve with age and frequently resolves or becomes substantially milder by late adolescence or early adulthood, which is genuinely reassuring information for families managing a young child through repeated flares.

The main determinant of long-term visual outcome is corneal involvement during the active disease years: patients who develop shield ulcers or significant keratopathy are at risk of permanent scarring and reduced vision if these complications are not caught and treated promptly, while patients whose disease stays limited to the conjunctiva generally do well long-term regardless of how uncomfortable individual flares have been.

Ongoing follow-up through the paediatric and adolescent years, with attention to corneal findings at every visit rather than symptom severity alone, is what keeps this disease from causing the vision loss it is capable of.

References

Bonini S, Coassin M, Aronni S, Lambiase A. Vernal keratoconjunctivitis. Eye. 2004.
Leonardi A. Management of vernal keratoconjunctivitis. Ophthalmology and Therapy. 2013.
Sacchetti M, Baiardini I, Lambiase A, et al. Vernal keratoconjunctivitis-related quality of life in children and adolescents. Pediatric Allergy and Immunology. 2018.
Vernal Keratoconjunctivitis. EyeWiki, American Academy of Ophthalmology.
Vernal Keratoconjunctivitis. StatPearls, NCBI Bookshelf.